Irinotecan + carboplatin improves outcomes in SCLC

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1536, 2006-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lenograstim improves survival without compromising QOL in SCLC

Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

By Wolf Köster

Clinical Drug Investigation, Vol. 24, Iss. 10, 2004-01 ,pp. : 611-618

Adis International

Access to resources Recommend Favorite

Telemanagement improves HF outcomes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 407, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The combination of irinotecan plus carboplatin has antitumour activity in non-small-cell lung cancer (NSCLC)

Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Good adherence improves health outcomes

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite